<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 1: Recurrent Pregnancy Loss (RPL): Clinical & Coaching Frameworks | AccrediPro</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Burgundy Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
}

/* TABLE OF CONTENTS */
.toc-box {
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
 gap: 10px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 12px;
 background: #f9fafb;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 color: #722F37;
 background: #f3f4f6;
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

/* BOXES */
.welcome-box {
 background: #fdf2f4;
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #722F37;
}

.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
}

.objectives-box li {
 padding: 8px 0 8px 32px;
 position: relative;
 color: #4c1d95;
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: #B8860B;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
}

.highlight {
 background: #fdf2f4;
 color: #722F37;
 font-weight: 600;
 padding: 2px 4px;
 border-radius: 4px;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 border-left: 6px solid #722F37;
 overflow: hidden;
 box-shadow: 0 10px 30px rgba(0,0,0,0.05);
}

.case-study-header {
 background: #fdf2f4;
 padding: 20px 28px;
}

.case-study-content {
 padding: 28px;
}

/* TABLES */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
}

.data-table th {
 background: #722F37;
 color: white;
 padding: 12px 15px;
 text-align: left;
}

.data-table td {
 padding: 12px 15px;
 border-bottom: 1px solid #e5e7eb;
}

.data-table tr:nth-child(even) {
 background: #f9fafb;
}

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* INTERACTIVE COMPONENTS */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}

.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}

.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}

.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}

.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}

.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
 list-style: disc;
}

.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: #f8fafc;
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 32px;
 margin-top: 48px;
}

.references-box ol {
 padding-left: 20px;
}

.references-box li {
 font-size: 14px;
 color: #475569;
 margin-bottom: 8px;
}

.module-connection {
 background: #f0f9ff;
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
}

 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 28: Crisis & Complex Cases</span>
 <h1 class="lesson-title">Recurrent Pregnancy Loss (RPL): Clinical & Coaching Frameworks</h1>
 <div class="lesson-meta">
 <span class="meta-badge">‚è±Ô∏è 14 min read</span>
 <span class="meta-badge">üéì Lesson 1 of 8</span>
 <span class="meta-badge">üõ°Ô∏è Level 3 Advanced</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Credential</div>
 <div class="title">AccrediPro Standards Institute ‚Ä¢ Advanced Clinical Protocol</div>
 </div>
 </div>

 <!-- Module Connection -->
 <div class="module-connection">
 <p><strong>Module Connection:</strong> While previous modules focused on the foundations of conception and cycle health, Module 28 pivots to the most challenging clinical scenarios. We begin with RPL, as it requires the highest level of <strong>Integrative Advocacy</strong> and emotional resilience.</p>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">In This Lesson</span>
 <ul class="toc-list">
 <li><a href="#defining-rpl"><span class="section-num">01</span>Redefining RPL for Proactive Care</a></li>
 <li><a href="#functional-assessment"><span class="section-num">02</span>The Functional Workup: Beyond the Basics</a></li>
 <li><a href="#immunology"><span class="section-num">03</span>Immunological Factors & "Sticky Blood"</a></li>
 <li><a href="#coaching-framework"><span class="section-num">04</span>The First Trimester Anxiety Framework</a></li>
 <li><a href="#advocacy"><span class="section-num">05</span>Integrative Advocacy for RPL Clients</a></li>
 </ul>
 </nav>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Mastering the Complexity of Loss</h3>
 <p>Recurrent Pregnancy Loss (RPL) is one of the most heartbreaking experiences a client can face. As a Certified Fertility Coach‚Ñ¢, your role is to bridge the gap between clinical investigation and emotional survival. This lesson provides the <strong>scientific literacy</strong> to help clients navigate medical testing and the <strong>coaching frameworks</strong> to support them through the paralyzing anxiety of a subsequent pregnancy.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Differentiate between the clinical definition of RPL and the proactive coaching standard for intervention.</li>
 <li>Identify the key functional markers for RPL, including thrombophilias, uterine anomalies, and karyotyping.</li>
 <li>Explain the mechanisms of Antiphospholipid Syndrome (APS) and Natural Killer (NK) cells in reproductive failure.</li>
 <li>Implement specialized coaching techniques to manage first-trimester trauma and anxiety.</li>
 <li>Advocate for evidence-based interventions like progesterone support and low-dose aspirin protocols.</li>
 </ul>
 </div>

 <h2 id="defining-rpl">Redefining RPL for Proactive Care</h2>
 <p>Historically, the medical community defined Recurrent Pregnancy Loss (RPL) as the loss of <strong>three or more</strong> consecutive pregnancies. For many women, especially those starting their families in their late 30s or early 40s, waiting for a third loss before initiating a workup is clinically negligent and emotionally devastating.</p>

 <p>The <span class="highlight">modern proactive standard</span>, supported by the American Society for Reproductive Medicine (ASRM), now suggests that an evaluation may be initiated after <strong>two consecutive clinical pregnancy losses</strong>. In the coaching space, we often advocate for "pre-conception optimization" after even a single loss, especially if maternal age is a factor.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Validating the "Two-Loss" Rule</span>
 <p>üí° Many clients feel they are "overreacting" by asking for testing after two losses. Remind them: "A 2021 study in <em>The Lancet</em> found that the risk of a subsequent miscarriage increases significantly after two losses (approx. 28%). Investigating now isn't being 'extra'‚Äîit's being evidence-based."</p>
 </div>

 <h2 id="functional-assessment">The Functional Workup: Beyond the Basics</h2>
 <p>When a client enters the RPL cycle, they often feel like their body is a "black box." A functional assessment aims to shine a light on the multi-factorial causes of loss. While 50% of RPL cases remain "unexplained" in conventional settings, functional investigation often reveals sub-clinical imbalances.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Category</th>
 <th>Standard Testing</th>
 <th>Functional/Advanced Considerations</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Anatomical</strong></td>
 <td>Ultrasound</td>
 <td>HSG (Hysterosalpingogram) or Saline Infusion Sonogram (SIS) to find polyps/septums.</td>
 </tr>
 <tr>
 <td><strong>Genetic</strong></td>
 <td>None (usually)</td>
 <td>Parental Karyotyping to rule out balanced translocations.</td>
 </tr>
 <tr>
 <td><strong>Endocrine</strong></td>
 <td>TSH only</td>
 <td>Full Thyroid Panel (T3, T4, Antibodies) and HbA1c for metabolic stability.</td>
 </tr>
 <tr>
 <td><strong>Hematologic</strong></td>
 <td>Basic CBC</td>
 <td>Inherited Thrombophilias (Factor V Leiden, Prothrombin gene mutation).</td>
 </tr>
 </tbody>
 </table>

 <h2 id="immunology">Immunological Factors & "Sticky Blood"</h2>
 <p>One of the most complex areas of RPL is <strong>Reproductive Immunology</strong>. The maternal immune system must undergo a massive "shift" to tolerate the semi-allogenic fetus (which contains 50% foreign DNA from the father). If this tolerance fails, the body may treat the pregnancy as a pathogen.</p>

 <h3>Antiphospholipid Syndrome (APS)</h3>
 <p>Often called "sticky blood," APS is an autoimmune condition where the body produces antibodies that attack phospholipids. This leads to micro-clots in the developing placenta, cutting off oxygen and nutrients to the embryo. This is a <strong>treatable</strong> cause of loss using Low-Dose Aspirin (LDA) and Heparin.</p>

 <h3>The Natural Killer (NK) Cell Debate</h3>
 <p>Natural Killer cells are a vital part of the uterine environment, helping to remodel the spiral arteries. However, an <strong>over-abundance</strong> or <strong>over-activity</strong> of peripheral NK cells is associated with RPL in some clinical subsets. While controversial in some conventional circles, many integrative REIs (Reproductive Endocrinologists) now test for and treat NK cell activity using intralipids or corticosteroids.</p>

 <div class="case-study">
 <div class="case-study-header">
 <strong>Case Study: Sarah, 41 (Former Nurse)</strong>
 </div>
 <div class="case-study-content">
 <p><strong>Profile:</strong> Sarah had three early losses (6-8 weeks) over 18 months. Her doctor told her it was "just age-related egg quality."</p>
 <p><strong>Intervention:</strong> As her coach, we used the <strong>I: Integrative Advocacy</strong> pillar to help her request an RPL panel. Testing revealed she was positive for <em>Anticardiolipin antibodies</em> (a marker for APS). </p>
 <p><strong>Outcome:</strong> Sarah's next pregnancy was supported by a Low Dose Aspirin and Lovenox protocol. She delivered a healthy baby girl at age 42. Sarah now runs a coaching practice specifically for "Medical Moms" facing loss, earning over $8,000/month in specialized group coaching.</p>
 </div>
 </div>

 <h2 id="coaching-framework">The First Trimester Anxiety Framework</h2>
 <p>For an RPL client, a positive pregnancy test is not a moment of joy‚Äîit is the start of a <strong>high-stakes crisis</strong>. The trauma of previous losses creates a state of hyper-vigilance where every twinge or lack of nausea is interpreted as a sign of impending death.</p>

 <p>As a coach, you implement the <strong>E: Emotional Resilience</strong> protocols specifically for the "PAL" (Pregnancy After Loss) phase:</p>
 <ul>
 <li><strong>Milestone Mapping:</strong> Breaking the 12 weeks into tiny, 3-day goals rather than looking at the whole trimester.</li>
 <li><strong>Somatic Checking:</strong> Using grounding techniques to distinguish between "Intuition" and "Trauma Response."</li>
 <li><strong>The "Safe for Now" Mantra:</strong> Helping the client stay in the present moment. "Today, I am pregnant."</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The Bathroom Trigger</span>
 <p>üí° For many RPL survivors, the bathroom is a place of trauma (where they first saw blood). Suggest they place a small, grounding object (a crystal, a quote, or a specific scent) in the bathroom to anchor them in the present during every "wipe check."</p>
 </div>

 <h2 id="advocacy">Integrative Advocacy for RPL Clients</h2>
 <p>Your role is to help the client speak the language of the clinic. The <strong>PRISM Trial (2019)</strong> provided landmark data on the use of progesterone in women with early pregnancy bleeding and a history of miscarriage. </p>

 <p><strong>Key Advocacy Points:</strong></p>
 <ol>
 <li><strong>Progesterone Support:</strong> If a client has 1+ previous losses, evidence suggests 400mg of vaginal progesterone twice daily starting from a positive test can improve live birth rates.</li>
 <li><strong>Low Dose Aspirin (LDA):</strong> Often started pre-conception to improve uterine blood flow, even in the absence of a formal APS diagnosis.</li>
 <li><strong>Early Scans:</strong> Requesting a "viability scan" at 6.5 weeks rather than waiting until 10-12 weeks to reduce the period of uncertainty.</li>
 </ol>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Male Factor in RPL</span>
 <p>üí° Don't forget the father! High <strong>Sperm DNA Fragmentation</strong> is a major contributor to recurrent loss. If the female workup is clear, advocate for a <em>Comet</em> or <em>SCSA</em> test for the partner. We cover this in depth in Module 4.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. According to the proactive coaching standard, after how many losses should a workup be considered?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans1')">Show Answer</button>
 <div id="ans1" class="answer-text">Evaluation should be considered after <strong>two</strong> consecutive clinical pregnancy losses, rather than the traditional three.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the mechanism behind Antiphospholipid Syndrome (APS) causing loss?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans2')">Show Answer</button>
 <div id="ans2" class="answer-text">APS causes "sticky blood," where antibodies trigger micro-clots in the placental vessels, depriving the embryo of oxygen and nutrients.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. What did the PRISM trial conclude regarding progesterone?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans3')">Show Answer</button>
 <div id="ans3" class="answer-text">It found that progesterone supplementation (400mg twice daily) significantly improved live birth rates in women with a history of miscarriage who experienced bleeding in early pregnancy.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. Why is Sperm DNA Fragmentation relevant to RPL?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans4')">Show Answer</button>
 <div id="ans4" class="answer-text">Even if an egg is fertilized, high levels of DNA damage in the sperm can lead to poor embryo development and subsequent early miscarriage, often around the 6-8 week mark.</div>
 </div>
 </div>

 <!-- Takeaways Box -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>RPL is a multi-factorial crisis requiring anatomical, genetic, endocrine, and immunological investigation.</li>
 <li>The "wait for three" rule is outdated; proactive coaching encourages investigation after two losses.</li>
 <li>Reproductive immunology (APS, NK cells) is a critical frontier for "unexplained" RPL cases.</li>
 <li>Coaching during a subsequent pregnancy requires specialized somatic and emotional tools to manage hyper-vigilance.</li>
 <li>Integrative advocacy empowers clients to request evidence-based support like progesterone and LDA early in the cycle.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Coomarasamy, A., et al. (2019). "A Randomized Trial of Progesterone in Women with Bleeding in Early Pregnancy (PRISM)." <em>New England Journal of Medicine</em>.</li>
 <li>Quenby, S., et al. (2021). "Miscarriage matters: the epidemiology, physical, psychological, and economic costs of early pregnancy loss." <em>The Lancet</em>.</li>
 <li>ASRM Practice Committee. (2020). "Evaluation and treatment of recurrent pregnancy loss: a committee opinion." <em>Fertility and Sterility</em>.</li>
 <li>Kaur, R., et al. (2023). "The role of sperm DNA fragmentation in recurrent pregnancy loss: A systematic review and meta-analysis." <em>Reproductive Biomedicine Online</em>.</li>
 <li>Branch, D. W., et al. (2018). "Antiphospholipid Syndrome and Pregnancy Loss." <em>Obstetrics & Gynecology</em>.</li>
 <li>Moffett, A., & Colucci, F. (2022). "Uterine NK cells: active agents at the maternal-fetal interface." <em>Journal of Clinical Investigation</em>.</li>
 </ol>
 </div>
</div>

<script>
function toggleAnswer(id) {
 const el = document.getElementById(id);
 if (el.style.display === 'block') {
 el.style.display = 'none';
 } else {
 el.style.display = 'block';
 }
}
</script>

</body>
</html>